Skip to main content
Equibles

FMR LLC

Position in GMAB — Genmab A/S

CIK 315066 BOSTON, MA
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$21,006,143
-$6,138,464 QoQ
Shares Held
764,694
-24.4% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 5% Shared 0% None 95%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. GMAB ranks #142 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in GMAB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,006,143 764,694
2026-03-31 $27,144,607 1,011,726
2025-12-31 $32,566,070 1,057,340
2025-09-30 $34,341,627 1,119,714
2025-06-30 $14,059,811 680,533
2025-03-31 $9,493,284 484,846
2024-12-31 $11,281,339 540,553
2024-09-30 $6,782,368 278,194
2024-06-30 $6,159,813 245,118
2024-03-31 $11,198,512 374,407
2023-12-31 $8,517,357 267,505
2023-09-30 $14,899,351 422,437
2023-06-30 $15,109,011 397,501
2023-03-31 $14,779,678 391,411
2022-12-31 $19,141,306 451,659
2022-09-30 $14,040,744 436,998
2022-06-30 $7,990,167 245,927
2022-03-31 $7,981,560 220,607
2021-12-31 $6,066,485 153,349
2021-09-30 $5,763,591 131,890
2021-06-30 $4,597,049 112,590
2021-03-31 $5,659,957 172,402
2020-12-31 $3,393,808 83,468
2020-09-30 $9,252,188 252,723
2020-06-30 $583,585 17,220
2020-03-31 $182,890 8,631